MedPath

Propofol Versus Sevoflurane for Induction of GA in Infants

Not Applicable
Recruiting
Conditions
Induction of General Anesthesia
Interventions
Registration Number
NCT05105022
Lead Sponsor
Cairo University
Brief Summary

This comparative study aims to investigate the haemodynamic safety profile for induction of general anesthesia in infants 3 months or less guided by electrical cardiometry parameters versus sevoflurane.

Detailed Description

This study aims to investigate the hemodynamic effects of both propofol and sevoflurane for induction of anesthesia in infants less than 3 months of age by electrical cardiometry. The investigators hypothesized that propofol will have a safe hemodynamic profile for induction of anesthesia in infants less than 3 months of age as measured by electrical cardiometry in addition to its favorable pharmacokinetic profile of rapid induction and optimal intubation conditions.It is conducted at Abu Al Reesh Children's Hospital, Faculty of Medicine, Cairo University based on an institutional protocol used as a standard of care to induce anesthesia

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
122
Inclusion Criteria
  • infants aged 3 months or less scheduled for elective surgery
Exclusion Criteria
  • significant structural congenital heart disease
  • intracranial malformation.
  • preexisting hemodynamic instability.
  • history of seizures, opioids, and/or hypnotic administration.
  • prematurity (defined as gestational age <37 weeks)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
propofolPropofolPropofol at a dose of 2mg/kg will be administered I.V. .
SevofluranePropofolSevoflurane (4%) will be used for inhalational induction.
Primary Outcome Measures
NameTimeMethod
cardiac index15 minutes

L/min/m2

Secondary Outcome Measures
NameTimeMethod
MAP15 minutes

mmHg

Trial Locations

Locations (1)

Faculty of Medicine- Cairo University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath